434 related articles for article (PubMed ID: 19581523)
21. SRC catalytic but not scaffolding function is needed for integrin-regulated tyrosine phosphorylation, cell migration, and cell spreading.
Cary LA; Klinghoffer RA; Sachsenmaier C; Cooper JA
Mol Cell Biol; 2002 Apr; 22(8):2427-40. PubMed ID: 11909938
[TBL] [Abstract][Full Text] [Related]
22. New Structural Perspectives in G Protein-Coupled Receptor-Mediated Src Family Kinase Activation.
Berndt S; Liebscher I
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204297
[TBL] [Abstract][Full Text] [Related]
23. The regulation of N-methyl-D-aspartate receptors by Src kinase.
Groveman BR; Feng S; Fang XQ; Pflueger M; Lin SX; Bienkiewicz EA; Yu X
FEBS J; 2012 Jan; 279(1):20-8. PubMed ID: 22060915
[TBL] [Abstract][Full Text] [Related]
24. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors.
Park SI; Shah AN; Zhang J; Gallick GE
Expert Opin Ther Targets; 2007 Sep; 11(9):1207-17. PubMed ID: 17845146
[TBL] [Abstract][Full Text] [Related]
25. Src family kinases differentially influence glioma growth and motility.
Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
[TBL] [Abstract][Full Text] [Related]
26. An Update on Src Family of Nonreceptor Tyrosine Kinases Biology.
Espada J; Martín-Pérez J
Int Rev Cell Mol Biol; 2017; 331():83-122. PubMed ID: 28325216
[TBL] [Abstract][Full Text] [Related]
27. Computational approaches for the identification and optimization of Src family kinases inhibitors.
Poli G; Martinelli A; Tuccinardi T
Curr Med Chem; 2014; 21(28):3281-93. PubMed ID: 25005179
[TBL] [Abstract][Full Text] [Related]
28. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
Johnson FM; Gallick GE
Anticancer Agents Med Chem; 2007 Nov; 7(6):651-9. PubMed ID: 18045060
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells.
Buettner R; Mesa T; Vultur A; Lee F; Jove R
Mol Cancer Res; 2008 Nov; 6(11):1766-74. PubMed ID: 19010823
[TBL] [Abstract][Full Text] [Related]
30. Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells.
Hirsch CL; Smith-Windsor EL; Bonham K
Int J Cancer; 2006 Feb; 118(3):547-54. PubMed ID: 16094635
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
[TBL] [Abstract][Full Text] [Related]
32. Targeting Src in breast cancer.
Finn RS
Ann Oncol; 2008 Aug; 19(8):1379-1386. PubMed ID: 18487549
[TBL] [Abstract][Full Text] [Related]
33. The interplay between Src family kinases and receptor tyrosine kinases.
Bromann PA; Korkaya H; Courtneidge SA
Oncogene; 2004 Oct; 23(48):7957-68. PubMed ID: 15489913
[TBL] [Abstract][Full Text] [Related]
34. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.
Kim MP; Park SI; Kopetz S; Gallick GE
Cell Tissue Res; 2009 Jan; 335(1):249-59. PubMed ID: 18815812
[TBL] [Abstract][Full Text] [Related]
35. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway.
Encinas M; Tansey MG; Tsui-Pierchala BA; Comella JX; Milbrandt J; Johnson EM
J Neurosci; 2001 Mar; 21(5):1464-72. PubMed ID: 11222636
[TBL] [Abstract][Full Text] [Related]
36. Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells.
Emaduddin M; Bicknell DC; Bodmer WF; Feller SM
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2358-62. PubMed ID: 18258742
[TBL] [Abstract][Full Text] [Related]
37. The role of SRC family kinases in FLT3 signaling.
Kazi JU; Rönnstrand L
Int J Biochem Cell Biol; 2019 Feb; 107():32-37. PubMed ID: 30552988
[TBL] [Abstract][Full Text] [Related]
38. Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients.
Roseweir AK; Qayyum T; Lim Z; Hammond R; MacDonald AI; Fraser S; Oades GM; Aitchison M; Jones RJ; Edwards J
BMC Cancer; 2016 Mar; 16():229. PubMed ID: 26984511
[TBL] [Abstract][Full Text] [Related]
39. Src family kinases in tumor progression and metastasis.
Summy JM; Gallick GE
Cancer Metastasis Rev; 2003 Dec; 22(4):337-58. PubMed ID: 12884910
[TBL] [Abstract][Full Text] [Related]
40. Purinergic agonists stimulate lens Na-K-ATPase-mediated transport via a Src tyrosine kinase-dependent pathway.
Tamiya S; Okafor MC; Delamere NA
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C790-6. PubMed ID: 17522142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
